Cumberland Pharmaceuticals Inc.
CPIX
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment oā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
16 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$6.68
Price-0.74%
-$0.05
1Y
Price
Market Cap
$100.087m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-9.6%
EBITDA Margin-23.4%
Net Profit Margin+2.0%
Free Cash Flow Margin-9.6%
EBITDA Margin-23.4%
Net Profit Margin+2.0%
Free Cash Flow MarginRevenue
$41.940m
+9.0%
1y CAGR-0.4%
3y CAGR+3.9%
5y CAGREarnings
-$7.232m
+48.6%
1y CAGR+10.9%
3y CAGR-6.5%
5y CAGREPS
-$0.49
+47.8%
1y CAGR+9.2%
3y CAGR-7.7%
5y CAGRBook Value
$21.303m
$70.995m
Assets$49.692m
Liabilities$10.070m
DebtDebt to Assets
14.2%
3.8x
Debt to EBITDAFree Cash Flow
$1.318m
+947.3%
1y CAGR+273.9%
3y CAGR+207.0%
5y CAGRNo items found.
Press Releases
Statements and updates from the company